We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Protext is a Biotech Company developing a Hemp/CBD -- Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Through its wholly owned subsidiary RSAMMD Acquisitions LLC ("RSAMMDA") and under the leadership of its founders Mr. Dy... Protext is a Biotech Company developing a Hemp/CBD -- Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Through its wholly owned subsidiary RSAMMD Acquisitions LLC ("RSAMMDA") and under the leadership of its founders Mr. Dylon Du Plooy and Dr. Ahmed Jamaloodeen we partner with leading hospitals and universities globally to advance the clinical benefits and applications of cannabinoids. Mr. Du Plooy is a South African pioneer in the research, cultivation, production and distribution of medical cannabis and cannabinoids. Dr. J operates a 5000-hectare farm in New Castle, South Africa and holds cannabis and hemp licenses issued by the Government of South Africa. Together the RSAMMDA founders have been at the forefront of medical cannabis legislation and South African cannabis legalization, which took place in September 2018. We are committed to the advancement of technology and scientific research that leads to an improved quality of life for patients around the world. Show more
PROTEXT PHARMA ANNOUNCES EXPANSION OF CANNABIS LICENSE AGREEMENT WITH MAJORITY SHAREHOLDER PLANDIA BIOTECHNOLOGY, INC. Florida, USA -- December 7, 2018 -- InvestorsHub NewsWire -- Protext...
PROTEXT PHARMA ANNOUNCES SUCCESSFUL COMPLETION OF GOVERNMENT INSPECTION OF PROPOSED MEDICAL CANNABIS SITE FACILITY Company to Target Inflammation and Pain Management Florida, USA...
PLANDAI BIOTECHNOLOGY PROVIDES CLARIFICATION ON RECENT UPDATES RELATING TO THE BUSINESS OF PROTEXT PHARMA Florida, USA -- May 23, 2018 -- InvestorsHub NewsWire -- Protext...
Company Looks to Raise up to $10 Million Through ICO Boston, MA -- January 25, 2018 -- InvestorsHub NewsWire -- Growprocess, Inc. ("Growprocess" or "the...
January 25, 2018 -- InvestorsHub NewsWire -- Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0018 | 0.002 | 0.0001 | 4780827 | 0.00160323 | CS |
4 | 0.0004 | 28.5714285714 | 0.0014 | 0.0021 | 0.0001 | 4554670 | 0.00171176 | CS |
12 | 0.001 | 125 | 0.0008 | 0.0021 | 0.0001 | 5168987 | 0.00118627 | CS |
26 | 0.00031 | 20.8053691275 | 0.00149 | 0.003 | 0.0001 | 9910585 | 0.00105832 | CS |
52 | 0.001 | 125 | 0.0008 | 0.0031 | 0.0001 | 7672514 | 0.00123684 | CS |
156 | -0.0005 | -21.7391304348 | 0.0023 | 0.02 | 0.0001 | 35658004 | 0.00506489 | CS |
260 | 0.0017 | 1700 | 0.0001 | 0.02 | 0.0001 | 50046340 | 0.00363942 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions